Fiona A van Vollenstee, Maria-Teresa van der Merwe
{"title":"肥胖及其对南非COVID-19大流行的影响","authors":"Fiona A van Vollenstee, Maria-Teresa van der Merwe","doi":"10.4102/sajid.v36i1.228","DOIUrl":null,"url":null,"abstract":"Obesity is a non-communicable disease associated with variety of a comorbidities, which includes: (1) metabolic diseases: type 2 diabetes mellitus (T2DM), metabolic associated fatty liver disease (non-alcoholic fatty liver disease [NAFLD] or non-alcoholic steatohepatitis [NASH]), dyslipidaemia and chronic inflammation, (2) respiratory diseases: chronic hypoventilation, sleep apnoea, chronic obstructive pulmonary disease and (3) cardiovascular diseases: hypertension, pulmonary embolism and coronary heart disease.2,3,4,5 Age < 60 years and co-morbidities linked to obesity are powerful predictors of hospitalisation length of stay, intensive care unit (ICU) admissions, higher morbidity and disease progression because of acute respiratory syndrome coronavirus-2 (COVID-19), despite correcting for comorbidities.3,4,5,6","PeriodicalId":44007,"journal":{"name":"Southern African Journal of Infectious Diseases","volume":"36 1","pages":"228"},"PeriodicalIF":1.4000,"publicationDate":"2021-04-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111705/pdf/","citationCount":"3","resultStr":"{\"title\":\"Obesity and its implications for COVID-19 pandemic in South Africa.\",\"authors\":\"Fiona A van Vollenstee, Maria-Teresa van der Merwe\",\"doi\":\"10.4102/sajid.v36i1.228\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Obesity is a non-communicable disease associated with variety of a comorbidities, which includes: (1) metabolic diseases: type 2 diabetes mellitus (T2DM), metabolic associated fatty liver disease (non-alcoholic fatty liver disease [NAFLD] or non-alcoholic steatohepatitis [NASH]), dyslipidaemia and chronic inflammation, (2) respiratory diseases: chronic hypoventilation, sleep apnoea, chronic obstructive pulmonary disease and (3) cardiovascular diseases: hypertension, pulmonary embolism and coronary heart disease.2,3,4,5 Age < 60 years and co-morbidities linked to obesity are powerful predictors of hospitalisation length of stay, intensive care unit (ICU) admissions, higher morbidity and disease progression because of acute respiratory syndrome coronavirus-2 (COVID-19), despite correcting for comorbidities.3,4,5,6\",\"PeriodicalId\":44007,\"journal\":{\"name\":\"Southern African Journal of Infectious Diseases\",\"volume\":\"36 1\",\"pages\":\"228\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2021-04-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111705/pdf/\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Southern African Journal of Infectious Diseases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4102/sajid.v36i1.228\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q4\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Southern African Journal of Infectious Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4102/sajid.v36i1.228","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
Obesity and its implications for COVID-19 pandemic in South Africa.
Obesity is a non-communicable disease associated with variety of a comorbidities, which includes: (1) metabolic diseases: type 2 diabetes mellitus (T2DM), metabolic associated fatty liver disease (non-alcoholic fatty liver disease [NAFLD] or non-alcoholic steatohepatitis [NASH]), dyslipidaemia and chronic inflammation, (2) respiratory diseases: chronic hypoventilation, sleep apnoea, chronic obstructive pulmonary disease and (3) cardiovascular diseases: hypertension, pulmonary embolism and coronary heart disease.2,3,4,5 Age < 60 years and co-morbidities linked to obesity are powerful predictors of hospitalisation length of stay, intensive care unit (ICU) admissions, higher morbidity and disease progression because of acute respiratory syndrome coronavirus-2 (COVID-19), despite correcting for comorbidities.3,4,5,6